Previous 10 | Next 10 |
2023-03-17 18:41:09 ET Summary Masimo Corporation shares fell off a cliff early in 2022 amidst the pullback in momentum names and a poorly received deal for Sound. I like the long-term trajectory of the business and gave management the benefit of the doubt, believing it was an ove...
Technologies Like Masimo SpHb ® Offer a “Practical Approach” to Perioperative Blood Management and “Timely Detection of Changes” Masimo (NASDAQ: MASI) today announced that updated guidelines published by the European Society of Anaesthesiology an...
Noninvasive, Continuous PVi Performed Well; Pressure-based Invasive Techniques Performed Poorly Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospi...
Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and Temple Health , Philadelphia’s 979-bed academic health system, announced today that they are entering into a strategic innovation collaboration. With an emphasis on advancing the fore...
Researchers Found That Noninvasive, Continuous PVi Was Equally Effective in Guiding Fluid Management As Stroke Volume Variation (SVV), an Invasive Method Requiring an Arterial Line Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British J...
Current Employment Agreement Undermines the Stockholder Franchise and Exerts ‘Dead Hand Control’ Over the Actions of All Future Boards Agreement Pays Approximately $600 million to CEO if the Board Merely Appoints a Lead Independent Director or if Stockholders Replace More Th...
Masimo (NASDAQ: MASI) today announced that its management will participate in the 44th Annual Raymond James Institutional Investors on Tuesday, March 7, 2023 at 11:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay o...
Masimo Corporation (MASI) Q4 2022 Earnings Conference Call February 28, 2023 04:30 PM ET Company Participants Eli Kammerman - Vice President of Business Development & Investor Relations Joe Kiani - Chairman & Chief Executive Officer Micah Young - Executive Vice...
The following slide deck was published by Masimo Corporation in conjunction with their 2022 Q4 earnings call. For further details see: Masimo Corporation 2022 Q4 - Results - Earnings Call Presentation
Masimo press release ( NASDAQ: MASI ): Q4 Non-GAAP EPS of $1.32 beats by $0.14 . Revenue of $617M (+88.4% Y/Y) beats by $14.51M . Full-Year 2022 Highlights: Consolidated revenue was $2,035.8 million; Healthcare revenue was $1,340.3 million, representi...
News, Short Squeeze, Breakout and More Instantly...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) will release second quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, August 6, 2024. The conference call to review the results will begin at 1...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...